A detailed history of Banco De Sabadell, S.A transactions in Eli Lilly & CO stock. As of the latest transaction made, Banco De Sabadell, S.A holds 4,533 shares of LLY stock, worth $3.76 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares
4,533
Previous 4,621 1.9%
Holding current value
$3.76 Million
Previous $3.6 Million 14.13%
% of portfolio
3.01%
Previous 2.68%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $63,788 - $79,995
-88 Reduced 1.9%
4,533 $4.1 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $170,553 - $228,176
-288 Reduced 5.87%
4,621 $3.6 Million
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $38,864 - $45,815
-74 Reduced 1.49%
4,909 $2.86 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $166,055 - $228,932
-382 Reduced 7.12%
4,983 $2.68 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $471,394 - $630,309
-1,344 Reduced 20.03%
5,365 $2.51 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $140,094 - $164,533
451 Added 7.21%
6,709 $2.3 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $435,057 - $506,928
-1,353 Reduced 17.78%
6,258 $2.29 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $27,869 - $31,759
94 Added 1.25%
7,611 $2.46 Million
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $370,153 - $434,614
-1,328 Reduced 15.01%
7,517 $2.44 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $95,284 - $118,413
406 Added 4.81%
8,845 $2.53 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $269,370 - $334,289
1,198 Added 16.54%
8,439 $2.33 Million
Q3 2021

Nov 04, 2021

SELL
$221.6 - $272.71 $11,966 - $14,726
-54 Reduced 0.74%
7,241 $1.68 Million
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $5.74 Million - $7.42 Million
-31,789 Reduced 81.34%
7,295 $1.67 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $2.75 Million - $3.57 Million
16,766 Added 75.12%
39,084 $7.28 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $392,293 - $519,098
-3,007 Reduced 11.87%
22,318 $3.75 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $1.7 Million - $1.96 Million
-11,612 Reduced 31.44%
25,325 $3.74 Million
Q2 2020

Aug 07, 2020

BUY
$136.42 - $164.18 $3.98 Million - $4.8 Million
29,209 Added 377.96%
36,937 $6.04 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $123,692 - $153,096
-1,039 Reduced 11.85%
7,728 $1.07 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $29,509 - $36,550
-276 Reduced 3.05%
8,767 $1.15 Million
Q3 2019

Nov 15, 2019

SELL
$106.79 - $116.16 $1.02 Million - $1.11 Million
-9,517 Reduced 51.28%
9,043 $1.01 Million
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $19,609 - $22,889
-177 Reduced 0.94%
18,560 $2.06 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $127,449 - $150,017
-1,145 Reduced 5.76%
18,737 $2.43 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $1.47 Million - $1.65 Million
-13,928 Reduced 41.19%
19,882 $2.27 Million
Q3 2018

Nov 16, 2018

SELL
$85.86 - $107.31 $304,287 - $380,306
-3,544 Reduced 9.49%
33,810 $3.62 Million
Q2 2018

Aug 15, 2018

BUY
$75.7 - $86.88 $1.53 Million - $1.76 Million
20,271 Added 118.66%
37,354 $3.19 Million
Q1 2018

May 16, 2018

BUY
$74.21 - $87.6 $101,816 - $120,187
1,372 Added 8.73%
17,083 $1.32 Million
Q4 2017

Feb 16, 2018

BUY
$81.94 - $87.89 $1.29 Million - $1.38 Million
15,711
15,711 $1.33 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Banco De Sabadell, S.A Portfolio

Follow Banco De Sabadell, S.A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.